Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · Real-Time Price · USD
3.500
+0.220 (6.71%)
Nov 7, 2024, 3:26 PM EST - Market open
Lantern Pharma Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Lantern Pharma.
Analyst Consensus: Hold
Analyst Ratings
According to 1 stock analyst, the rating for Lantern Pharma is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 2 | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Apr 25, 2024 |
EF Hutton | EF Hutton | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +214.29% | Aug 10, 2023 |
EF Hutton | EF Hutton | Strong Buy Maintains $11 | Strong Buy | Maintains | $11 | +214.29% | Jun 26, 2023 |
EF Hutton | EF Hutton | Strong Buy Initiates $11 | Strong Buy | Initiates | $11 | +214.29% | May 25, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Hold Initiates n/a | Hold | Initiates | n/a | n/a | May 18, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.16
from -1.47
EPS Next Year
-2.06
from -2.16
Revenue Forecast
Revenue | 2024 | 2025 | 2026 |
---|---|---|---|
High | n/a | n/a | n/a |
Avg | n/a | n/a | n/a |
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -2.23 | -2.12 | -1.20 |
Avg | -2.16 | -2.06 | -1.16 |
Low | -2.08 | -1.98 | -1.12 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.